Synergistic antiviral effect of PEG-asparaginase (ONCASPAR), with protease inhibitor alone and in combination with RT inhibitors against HIV-1 infected T-cells: a model of HIV-1-induced T-cell lymphoma. (Q40715422)
Jump to navigation
Jump to search
scientific article published on January 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Synergistic antiviral effect of PEG-asparaginase (ONCASPAR), with protease inhibitor alone and in combination with RT inhibitors against HIV-1 infected T-cells: a model of HIV-1-induced T-cell lymphoma. |
scientific article published on January 2001 |
Statements
Synergistic antiviral effect of PEG-asparaginase (ONCASPAR), with protease inhibitor alone and in combination with RT inhibitors against HIV-1 infected T-cells: a model of HIV-1-induced T-cell lymphoma (English)
V I Avramis
R Kwock
I A Avramis
L J Cohen
1 January 2001